180 related articles for article (PubMed ID: 7845151)
1. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
[No Abstract] [Full Text] [Related]
2. Lamivudine useful against hepatitis B-HIV co-infection.
Prescott LM
J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):34. PubMed ID: 11362610
[TBL] [Abstract][Full Text] [Related]
3. Viral dynamics in hepatitis B virus infection.
Nowak MA; Bonhoeffer S; Hill AM; Boehme R; Thomas HC; McDade H
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4398-402. PubMed ID: 8633078
[TBL] [Abstract][Full Text] [Related]
4. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.
Benhamou Y; Katlama C; Lunel F; Coutellier A; Dohin E; Hamm N; Tubiana R; Herson S; Poynard T; Opolon P
Ann Intern Med; 1996 Nov; 125(9):705-12. PubMed ID: 8929003
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B reactivation after lamivudine.
Honkoop P; de Man RA; Heijtink RA; Schalm SW
Lancet; 1995 Oct; 346(8983):1156-7. PubMed ID: 7475613
[No Abstract] [Full Text] [Related]
6. Immunodeficiency and new treatment for HBV.
Benhamou Y
Nurs Stand; 1995 Mar 1-7; 9(23):14. PubMed ID: 7703142
[No Abstract] [Full Text] [Related]
7. Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient.
Thabut D; Thibault V; Benhamou Y; Bernard B; Aubron-Olivier C; Poynard T; Di Martino V
AIDS; 2001 Dec; 15(18):2463-4. PubMed ID: 11774835
[No Abstract] [Full Text] [Related]
8. Lamivudine: a magic bullet for chronic hepatitis B?
Grimm I
Gastroenterology; 1996 Jul; 111(1):262-4. PubMed ID: 8698214
[No Abstract] [Full Text] [Related]
9. Lamivudine and famciclovir treatment in HIV patients with acute hepatitis B virus infection and hepatitis B reactivation.
Panos GZ; Lampropoulos KM; Angelousi AG; Charatsis GG; Falagas ME
J Clin Gastroenterol; 2007 Feb; 41(2):222-3. PubMed ID: 17245225
[No Abstract] [Full Text] [Related]
10. In vitro evaluation of combination therapies against hepatitis B virus replication.
Korba BE
Antiviral Res; 1996 Jan; 29(1):49-51. PubMed ID: 8721544
[TBL] [Abstract][Full Text] [Related]
11. PHS recommends preventive drugs for HIV exposures.
OR Manager; 1996 Aug; 12(8):1, 6. PubMed ID: 10161372
[No Abstract] [Full Text] [Related]
12. A quarter-century of antiviral therapy.
Merigan TC
N Engl J Med; 1995 Dec; 333(25):1704-5. PubMed ID: 7477225
[No Abstract] [Full Text] [Related]
13. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
14. The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).
Haverkamp M; Smit M; Weersink A; Boucher CA; Hoepelman AI
AIDS; 2003 Jul; 17(10):1572-4. PubMed ID: 12824802
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of hepatitis B virus replication accompanied by acute hepatitis in patients receiving highly active antiretroviral therapy.
Manegold C; Hannoun C; Wywiol A; Dietrich M; Polywka S; Chiwakata CB; Günther S
Clin Infect Dis; 2001 Jan; 32(1):144-8. PubMed ID: 11118394
[TBL] [Abstract][Full Text] [Related]
16. (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (524W91) inhibits hepatitis B virus replication in primary human hepatocytes.
Condreay LD; Condreay JP; Jansen RW; Paff MT; Averett DR
Antimicrob Agents Chemother; 1996 Feb; 40(2):520-3. PubMed ID: 8834915
[TBL] [Abstract][Full Text] [Related]
17. Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.
Goffin E; Horsmans Y; Cornu C; Squifflet JP; Pirson Y
Transplantation; 1998 Aug; 66(3):407-9. PubMed ID: 9721816
[No Abstract] [Full Text] [Related]
18. [Advance in clinical studies of the kinetics of hepatitis B virus].
Tang YT; Cao Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
[No Abstract] [Full Text] [Related]
19. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges.
Feld J; Locarnini S
J Clin Virol; 2002 Dec; 25(3):267-83. PubMed ID: 12423691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
